The Future of Cancer Care |
Tackling the Burden of a Life-Threatening Disease |
DECEMBER 14th | 9:00 a.m. EST | IN-PERSON |
|
|
In partnership with Burjeel Holdings |
As cancer rates rise, detection, treatment and prevention are becoming more critical to ensuring healthy populations around the globe. Advancements in healthcare technologies, especially artificial intelligence, are creating an optimistic landscape, however more still needs to be done to ensure equity and access for individuals, particularly in low-and- middle income countries. Amidst this ever-evolving landscape, join
Foreign Policy, in partnership with Burjeel Holdings on the 10th anniversary of their oncology conference, to discuss the future of cancer care and the promise of a future where this disease is treatable—if not preventable. |
|
|
| Dr. Catharine Young
Head of Global Oncology, Office of Science and Technology (OSTP), The White House |
| |
|
Rep. Mike Kelly
United States Member of Congress (R-PA) |
| Juan Pablo Uribe
Global Director, Health, Nutrition & Population and the Global Financing Facility, World Bank |
|
|
Danielle Bitterman
Radiation Oncologist and AI Researcher, Brigham and Women's Hospital/Dana-Farber Cancer Institute |
| Dr. Julie R. Gralow
Chief Medical Officer (CMO) and Executive Vice President, American Society of Clinical Oncology |
| Dr. Jason Hipp
Chief Digital Innovation Officer, Mayo Collaborative Services, Mayo Clinic |
|
|
Want to receive FP newsletters? Manage your FP newsletter preferences. |
Foreign Policy is a division of Graham Holdings Company. All contents © 2023 Graham Digital Holding Company LLC. All rights reserved. Foreign Policy, 655 15th St NW, Suite 300, Washington, DC, xxxxxx. |
|
|
|
